Efficacy and adverse events of sacral nerve stimulation for overactive bladder: A systematic review

Neurourology and Urodynamics

Volumn 29, Issue SUPPL. 1, 2010, Pages

  Siddiqui, Nazema Y ^a   Wu, Jennifer M ^a   Amundsen, Cindy L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

electric stimulation; overactive bladder; sacral neuromodulation; systematic review; urge; urinary bladder; urinary incontinence

Indexed keywords

CLINICAL EFFECTIVENESS; COCHRANE LIBRARY; EMBASE; FOREIGN BODY; HUMAN; INFECTION; LUMBOSACRAL PLEXUS; MEDLINE; NERVE STIMULATION; OVERACTIVE BLADDER; PAIN; REVIEW; SECOND LOOK SURGERY; SYSTEMATIC REVIEW; WOUND COMPLICATION; ADULT; AGED; BLADDER; DEVICE REMOVAL; ELECTROSTIMULATION THERAPY; EQUIPMENT DESIGN; FEMALE; INNERVATION; INSTRUMENTATION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; TREATMENT OUTCOME; URODYNAMICS;

ADULT; AGED; AGED, 80 AND OVER; DEVICE REMOVAL; ELECTRIC STIMULATION THERAPY; EQUIPMENT DESIGN; FEMALE; HUMANS; LUMBOSACRAL PLEXUS; MALE; MIDDLE AGED; TREATMENT OUTCOME; URINARY BLADDER; URINARY BLADDER, OVERACTIVE; URODYNAMICS; YOUNG ADULT;

EID: 77955928943     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20786     Document Type: Review

References (20)

1. Abrams P, Cardozo L, Fall M,. et al. The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-78. (Pubitemid 34195211)
2. Hassouna MM, Siegel SW, Nyeholt A, et al. Sacral neuromodulation in the treatment of urgency-frequency symptoms: A multicenter study on efficacy and safety. J Urol 2000; 163: 1849-54.
3. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
4. Amundsen CL, Romero AA, Jamison MG, et al. Sacral neuromodulation for intractable urge incontinence: Are there factors associated with cure? Urology 2005; 66: 746-50.
5. Schmidt RA, Jonas U, Oleson KA, et al. Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group. J Urol 1999; 162: 352-7.
6. Spinelli M, Weil E, Ostardo E, et al. New tined lead electrode in sacral neuromodulation: Experience from a multicentre European study. World J Urol 2005; 23: 225-9.
7. Siegel SW, Catanzaro F, Dijkema HE, et al. Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention. Urology 2000; 56: 87-91.
8. van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: Outcomes of a prospective, worldwide clinical study. J Urol 2007; 178: 2029-34.
9. Aboseif SR, Kim DH, Rieder JM, et al. Sacral neuromodulation: Cost considerations and clinical benefits. Urology 2007; 70: 1069-73; discussion 1073-64.
10. Hijaz A, Vasavada SP, Daneshgari F, et al. Complications and troubleshooting of two-stage sacral neuromodulation therapy: A single-institution experience. Urology 2006; 68: 533-7.
11. Van Voskuilen AC, Oerlemans D, Weil EHJ, et al. Medium-term experience of sacral neuromodulation by tined lead implantation. BJU Int 2007; 99: 107-10.
12. Guralnick ML, Benouni S, O'Connor RC, et al. Characteristics of infections in patients undergoing staged implantation for sacral nerve stimulation. Urology 2007; 69: 1073-6.
13. Das AK, Carlson AM, Hull M,. Improvement in depression and health-related quality of life after sacral nerve stimulation therapy for treatment of voiding dysfunction. Urology 2004; 64: 62-8.
14. Foster RT, Sr., Anoia EJ, Webster GD, et al. In patients undergoing neuromodulation for intractable urge incontinence a reduction in 24-hr pad weight after the initial test stimulation best predicts long-term patient satisfaction. Neurourol Urodyn 2007; 26: 213-7.
15. Janknegt RA, Hassouna MM, Siegel SW, et al. Long-term effectiveness of sacral nerve stimulation for refractory urge incontinence. Eur Urol 2001; 39: 101-6.
16. Blandon RE, Gebhart JB, Lightner DJ, et al. Re-operation rates after permanent sacral nerve stimulation for refractory voiding dysfunction in women. BJU Int 2008; 101: 1119-23.
17. Borawski KM, Foster RT, Webster GD, et al. Predicting implantation with a neuromodulator using two different test stimulation techniques: A prospective randomized study in urge incontinent women. Neurourol Urodyn 2007; 26: 14-8.
18. Sutherland SE, Lavers A, Carlson A, et al. Sacral nerve stimulation for voiding dysfunction: One institution's 11-year experience. Neurourol Urodyn 2007; 26: 19-28; discussion 36.
19. Leong R, Weil E, de Bie R, et al. PNE vs 1st stage tined lead: Which one is a better screening test for sacral neuromodulation? Neurourol Urodyn 2008; 27: 689-90.
20. Siddiqui NY, Amundsen CL, Corey EG, et al. Lead migration after sacral neuromodulation: Fascial versus tined anchoring systems. J Pelvic Med Surg 2008; 14: 338-9.